Results 191 to 200 of about 18,762 (211)

Baricitinib

Reactions Weekly, 2022
  +9 more sources

Baricitinib

Reactions Weekly, 2018
Wie Tofacitinib ein Januskinase-Hemmer, kann Baricitinib bei der rheumatoiden Arthritis eingesetzt werden, wenn Methotrexat nicht genügend wirkt oder nicht vertragen wird. Das Nutzen-Risiko-Verhältnis einer langfristigen Verabreichung von Januskinase-Hemmern ist jedoch noch ungenügend definiert.
openaire   +2 more sources

Baricitinib

Reactions Weekly, 2021
openaire   +2 more sources

Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques

Cell, 2021
Timothy N Hoang, Maria Pino, Amit A Upadhyay   +2 more
exaly  

Baricitinib

Reactions Weekly, 2019
  +4 more sources

Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials

EClinicalMedicine, 2022
Vijairam Selvaraj, Arkadiy Finn, Amos Lal   +2 more
exaly  

Effect of pH, temperature and native cyclodextrins on aqueous solubility of baricitinib

Journal of Molecular Liquids, 2022
Mikhail Agafonov, Ilya A Khodov, I V Terekhova   +2 more
exaly  

Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019

Clinical Infectious Diseases, 2021
Randi Connor-Schuler, Sushma K Cribbs, Jesse O'Shea   +2 more
exaly  

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)

Lancet, The, 2023
Michelle Petri, Daniel J Wallace, Marta Mosca   +2 more
exaly  

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

Lancet, The, 2023
Michelle Petri, Kenneth C Kalunian, Marta Mosca   +2 more
exaly